Advanced Enzyme Technologies Ltd

Advanced Enzyme Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Advanced Enzyme Technologies Ltd

₹ 360 0.10%
16 Apr - close price
advancedenzymes.com BSE: 540025 NSE : ADVENZYMES
About

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

Key Points

Market Position
The Co. is the 1st Indian enzyme company with 2nd highest market share in India. It is the 2nd listed integrated enzyme player globally. [1]

Website BSE NSE
  • Market Cap ₹ 4,023 Cr.
  • Current Price ₹ 360
  • High / Low ₹ 425 / 249
  • Stock P/E 28.7
  • Book Value ₹ 112
  • Dividend Yield 1.11 %
  • ROCE 11.9 %
  • ROE 9.23 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Promoter holding has decreased over last quarter: -2.30%
  • The company has delivered a poor sales growth of 6.69% over past five years.
  • Company has a low return on equity of 12.0% over last 3 years.
  • Dividend payout has been low at 8.94% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
138 133 137 127 134 132 121 139 142 139 147 158 161
71 78 74 78 85 91 90 99 100 95 103 107 107
Operating Profit 66 55 63 49 49 40 31 40 42 44 44 51 54
OPM % 48% 41% 46% 39% 37% 31% 26% 29% 29% 32% 30% 32% 33%
1 2 1 1 1 3 2 4 9 7 7 6 14
Interest 0 0 0 0 0 1 1 1 1 1 1 1 1
Depreciation 6 9 8 9 9 9 9 9 9 8 9 9 9
Profit before tax 61 48 55 41 41 34 24 34 40 42 41 48 59
Tax % 27% 29% 27% 27% 31% 26% 26% 23% 31% 24% 29% 27% 28%
44 34 40 30 29 25 18 26 28 32 29 35 42
EPS in Rs 3.86 2.81 3.40 2.66 2.46 2.19 1.60 2.34 2.63 2.87 2.58 3.08 3.74
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
171 219 239 222 293 329 391 420 444 502 529 541 605
109 130 189 131 155 177 226 236 241 269 327 382 412
Operating Profit 62 90 50 91 138 152 165 184 203 233 203 158 193
OPM % 36% 41% 21% 41% 47% 46% 42% 44% 46% 46% 38% 29% 32%
3 4 1 1 -3 3 1 5 6 9 6 21 34
Interest 12 10 13 9 8 4 9 5 4 3 3 3 3
Depreciation 6 8 10 9 9 13 18 21 26 29 35 35 34
Profit before tax 48 76 28 74 118 137 139 162 179 210 171 140 190
Tax % 29% 34% 23% 31% 35% 32% 33% 28% 26% 28% 28% 26%
34 50 21 51 77 93 94 116 133 151 124 104 139
EPS in Rs 3.22 4.52 1.85 4.60 6.97 8.20 8.07 9.95 11.58 13.06 10.70 9.45 12.27
Dividend Payout % 1% 7% 6% 4% 3% 5% 6% 6% 5% 7% 9% 11%
Compounded Sales Growth
10 Years: 9%
5 Years: 7%
3 Years: 7%
TTM: 13%
Compounded Profit Growth
10 Years: 8%
5 Years: 4%
3 Years: -6%
TTM: 46%
Stock Price CAGR
10 Years: %
5 Years: 13%
3 Years: 0%
1 Year: 40%
Return on Equity
10 Years: 16%
5 Years: 14%
3 Years: 12%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 21 22 22 22 22 22 22 22 22 22 22 22 22
Reserves 75 140 145 188 256 442 537 657 817 949 1,066 1,213 1,226
207 186 167 115 101 54 67 35 28 28 35 34 39
46 48 73 92 71 65 102 91 104 150 137 142 157
Total Liabilities 349 396 406 417 450 583 727 805 971 1,149 1,260 1,411 1,444
204 287 287 287 285 421 491 495 563 604 619 649 653
CWIP 60 2 2 5 7 8 11 10 10 10 15 22 17
Investments 0 0 0 0 0 0 0 111 124 121 102 360 342
84 107 117 125 158 153 226 188 275 414 524 380 432
Total Assets 349 396 406 417 450 583 727 805 971 1,149 1,260 1,411 1,444

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
49 41 43 54 93 107 116 129 141 163 122 140
-187 -40 -25 -15 -10 -60 -60 -124 -43 -27 2 -286
128 -3 -20 -36 -63 -65 -2 -43 -39 -26 -48 -26
Net Cash Flow -10 -2 -1 2 21 -18 54 -38 60 109 75 -171

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 70 65 49 61 52 55 55 51 61 63 61 68
Inventory Days 222 318 387 403 358 352 339 363 361 346 402 343
Days Payable 139 121 81 89 68 57 78 46 43 56 60 67
Cash Conversion Cycle 152 262 356 374 342 351 315 369 379 353 404 344
Working Capital Days 60 95 5 -4 40 106 82 90 100 104 122 117
ROCE % 28% 26% 12% 25% 36% 31% 25% 24% 22% 22% 15% 12%

Shareholding Pattern

Numbers in percentages

10 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
52.30% 52.55% 52.71% 52.70% 52.70% 49.88% 49.88% 49.88% 46.52% 45.92% 43.62% 43.49%
16.40% 16.27% 16.39% 18.01% 18.72% 21.68% 21.74% 21.86% 21.89% 22.27% 22.54% 23.01%
8.46% 8.66% 8.99% 6.90% 6.26% 5.60% 5.64% 5.73% 7.58% 6.49% 6.98% 7.56%
22.84% 22.52% 21.91% 22.38% 22.32% 22.86% 22.76% 22.54% 24.02% 25.34% 26.88% 25.94%
No. of Shareholders 79,25487,11284,34686,57384,37684,27781,18377,53775,05272,64273,03468,640

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls